The deal, which the OxyContin-maker says is worth $10 billion, is to settle thousands of lawsuits against the company for its alleged role in fueling the opioid crisis.
Purdue Pharma’s Creditors Vote Yes To Bankruptcy Deal Shielding Billionaire Owners From Future Opioid Lawsuits
